613 related articles for article (PubMed ID: 7779242)
21. Apomorphine-induced prepulse inhibition disruption is associated with a paradoxical enhancement of prepulse stimulus reactivity.
Yee BK; Russig H; Feldon J
Neuropsychopharmacology; 2004 Feb; 29(2):240-8. PubMed ID: 14666120
[TBL] [Abstract][Full Text] [Related]
22. The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.
Frau R; Mosher LJ; Bini V; Pillolla G; Pes R; Saba P; Fanni S; Devoto P; Bortolato M
Psychoneuroendocrinology; 2016 Jan; 63():59-67. PubMed ID: 26415119
[TBL] [Abstract][Full Text] [Related]
23. The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice.
Ralph RJ; Varty GB; Kelly MA; Wang YM; Caron MG; Rubinstein M; Grandy DK; Low MJ; Geyer MA
J Neurosci; 1999 Jun; 19(11):4627-33. PubMed ID: 10341260
[TBL] [Abstract][Full Text] [Related]
24. Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation.
Weber M; Chang WL; Breier M; Ko D; Swerdlow NR
Behav Pharmacol; 2008 Dec; 19(8):786-95. PubMed ID: 19020413
[TBL] [Abstract][Full Text] [Related]
25. Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats.
Gogos A; van den Buuse M
Schizophr Res; 2015 Nov; 168(3):634-9. PubMed ID: 25979306
[TBL] [Abstract][Full Text] [Related]
26. Role of nicotinic receptors in the lateral habenula in the attenuation of amphetamine-induced prepulse inhibition deficits of the acoustic startle response in rats.
Larrauri JA; Burke DA; Hall BJ; Levin ED
Psychopharmacology (Berl); 2015 Aug; 232(16):3009-17. PubMed ID: 25912180
[TBL] [Abstract][Full Text] [Related]
27. Excitation of type II anterior caudate neurons by stimulation of dopamine D3 receptors.
Piercey MF; Hyslop DK; Hoffmann WE
Brain Res; 1997 Jul; 762(1-2):19-28. PubMed ID: 9262154
[TBL] [Abstract][Full Text] [Related]
28. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
[TBL] [Abstract][Full Text] [Related]
29. Assessment of D3 versus D2 receptor modulation of the discriminative stimulus effects of (+)-7-OH-DPAT in rats.
Baker LE; Hood CA; Heidema AM
Behav Pharmacol; 1999 Dec; 10(8):717-22. PubMed ID: 10780286
[TBL] [Abstract][Full Text] [Related]
30. Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man.
Martin-Iverson MT
J Psychopharmacol; 1999; 13(2):198-9. PubMed ID: 10475729
[No Abstract] [Full Text] [Related]
31. Dissociable effects of the
Lins BR; Marks WN; Phillips AG; Howland JG
Psychopharmacology (Berl); 2017 Apr; 234(7):1079-1091. PubMed ID: 28180960
[TBL] [Abstract][Full Text] [Related]
32. Startle and sensorimotor gating in rats lacking CCK-A receptors.
Feifel D; Priebe K; Shilling PD
Neuropsychopharmacology; 2001 Jun; 24(6):663-70. PubMed ID: 11331146
[TBL] [Abstract][Full Text] [Related]
33. Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors.
Dall'Olio R; Gaggi R; Voltattorni M; Tanda O; Gandolfi O
Behav Pharmacol; 2002 Dec; 13(8):633-8. PubMed ID: 12478213
[TBL] [Abstract][Full Text] [Related]
34. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats.
Oliveras I; Sánchez-González A; Sampedro-Viana D; Piludu MA; Río-Alamos C; Giorgi O; Corda MG; Aznar S; González-Maeso J; Gerbolés C; Blázquez G; Cañete T; Tobeña A; Fernández-Teruel A
Psychopharmacology (Berl); 2017 Mar; 234(6):957-975. PubMed ID: 28154892
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats.
Jones CK; Eberle EL; Shaw DB; McKinzie DL; Shannon HE
J Pharmacol Exp Ther; 2005 Mar; 312(3):1055-63. PubMed ID: 15574685
[TBL] [Abstract][Full Text] [Related]
37. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.
Halberstadt AL; Geyer MA
Psychopharmacology (Berl); 2010 Feb; 208(2):179-89. PubMed ID: 19937319
[TBL] [Abstract][Full Text] [Related]
38. Quinelorane, a dopamine D3/D2 receptor agonist, reduces prepulse inhibition of startle and ventral pallidal GABA efflux: time course studies.
Qu Y; Swerdlow NR; Weber M; Stouffer D; Parsons LH
Pharmacol Biochem Behav; 2008 Oct; 90(4):686-90. PubMed ID: 18579193
[TBL] [Abstract][Full Text] [Related]
39. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
Audinot V; Newman-Tancredi A; Gobert A; Rivet JM; Brocco M; Lejeune F; Gluck L; Desposte I; Bervoets K; Dekeyne A; Millan MJ
J Pharmacol Exp Ther; 1998 Oct; 287(1):187-97. PubMed ID: 9765337
[TBL] [Abstract][Full Text] [Related]
40. Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology.
Gogos A; Bogeski M; van den Buuse M
Behav Pharmacol; 2008 Sep; 19(5-6):548-61. PubMed ID: 18690109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
